MS ECHO Session 2: Role of neuroimaging for MS diagnosis and MS management Gary Stobbe, MD Medical Director, MS Project ECHO Clinical Assistant Professor, UW Neurology Annette Wundes, MD Medical Director, UW Multiple Sclerosis Center Associate Professor, UW Neurology
19
Embed
MS ECHO Session 2: Role of neuroimaging for MS diagnosis ...echo.msrrtc.washington.edu/sites/echo/files/files...Gary Stobbe, MD Medical Director, MS Project ECHO . Clinical Assistant
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
MS ECHO Session 2: Role of neuroimaging for MS
diagnosis and MS management
Gary Stobbe, MD Medical Director, MS Project ECHO
Clinical Assistant Professor, UW Neurology
Annette Wundes, MD Medical Director, UW Multiple Sclerosis Center
Associate Professor, UW Neurology
Conflict of Interest:
• Dr. Stobbe – No conflicts of interest to disclose
• Dr. Wundes – No conflicts of interest pertaining to this
presentation – Research funding: Biogen Idec
2
Educational Objectives • Review MRI terminology and basics relevant
to MS • Understand MRI criteria for MS diagnosis
and differential • Understand the role of MRI in monitoring MS
disease and response to treatment • Recognize MRI limitations
3
MRI terminology and basics
Of interest in MS: •Three types of lesions •Location
T2/FLAIR lesions = overall lesion load
• T2-hyperintense lesions: “white spots” on both brain and spine
• FLAIR lesions (or STIR lesions on spine): “white spots” can be easier picked up b/o spinal fluid is black rather than white
FLAIR T2
By itself just a structural change non-specific – gliosis, small vessel changes, normal aging, demyelinating most lesions do not go away – “burden of disease” (BoD) New lesions over time demonstrate disease progression in MS
Before administration of contrast dye
After administration of contrast dye
Contrast-enhancing lesions = evidence of acute inflammation
(T1 sequence)
T1 black hole = focal loss of nerve fiber/scar
FLAIR for white spots T1 for “black holes”
(AKA “T1 hypodensity”, “T1 hypodense lesions”)
Classical locations and morphology of MS lesions
Periventricular
“Dawson’s fingers”
Subcortical
Spine lesions
Corpus callosum
Case B - Overview • 29 yo single mother, 2011 establishing care with newly diagnosed RRMS • no relevant prior hx/family hx • 2009 diffuse sensory sx neck area, then progressive sx R>L ON, no IVMP b/o
delay in diagnosis ON. Outside brain and C-spine MRI negative. • Mid 2010 abdominal cramping and rectal urgency w/o identified etiology x 3m • Dec 2010 progressive sensory sx RUE, R torso, RLE x 3 weeks • Mar 2011 numbness L hand x 1m • May 2011 R ON, L hand numbness, Lhermitte
Brain MRI: Multifocal WM lesions c/w MS, at least 4 enhancing lesions Neuro-ophthalomology: agree ON 3 day IVMP
Presenter
Presentation Notes
Multifocal WM disease in both hemispheres c/w MS. Some of the lesions are periventricular and at least 1 lesion is within the corpus callosum. At least 4 lesions are contrast enhancing
Case B FLAIR lesions 2011 (2009 none)
Case B FLAIR lesions 2011 (2009 none)
Case B Contrast-enhancing lesions (at least4)
Case B T1 hypointense lesions (“black hole”)
Diagnostic criteria for MS
DIS (dissemination in space)
≥1 T2lesion in each of ≥ 2 of 4 characteristic locations: • Periventricular • Juxtacortical • Posterior fossa • Spinal cord
*Symptomatic lesions in brainstem and cord syndromes excluded
DIT (dissemination in time)
• Any new T2 lesion -- regardless of timing
• If simultaneously contrast-enhancing and non-enhancing lesion at the same time
Revised Mc Donald MRI criteria: “any two, any new”
Sensitivity 72%, specificity ~90%, Polman et al., Ann Neurology 2011
Differential Diagnosis: Brain MRI findings often nonspecific
There is some overlap of MRI presentations. Context of clinical history and neurological findings on exam matters!
Migraines
Microvascular changes
Multiple sclerosis
(Rule of thumb: 65% of 65yo!)
Images courtesy of UW neuroradiologist D. Shibata
Presenter
Presentation Notes
Common things are common!
Spine lesions
MS – minimal cord swelling - < 2 vertebral segments - only part of cord in cross section
Adapted after Freedman et al, Can J Neurol Sci 31:157 (2004) and Can J Neurol Sci40:307 (2013)
• Provides info re underlying disease progress • New T2/FLAIR lesions or contrast-enhancing lesions?
Be aware of MRI limitations • Quality matters
• MS protocol (see resources for CMSC protocol) • 3 Tesla considered “golden standard” in MS at this point • Direct comparison to prior MRI • Slice thickness • Post-contrast images
• Clinical/ MRI mismatch
• Relevant area scanned, consider spine MRI if needed
• Known to be insensitive for • Cortical lesion load (assume most of your patients have them) • Neuro-degenerative changes • Atrophy difficult to quantify on standard MRI
Presenter
Presentation Notes
Quality of MRI MS protocol Clinical / MRI mismatch Insensitive for cortical lesion load, neuro-degnerative changes
Resources
• Consortium of MS Centers MRI Protocol for the Diagnosis and Follow-up of MS – Provides guidance on what type of scan to order in setting of new diagnosis,
MS monitoring, technical MRI specifics and recommendation on MRI report for MS work up and monitoring
• Professional Resource Center (www.NationalMSSociety.org/PRC ) – Prototypical MRI findings in MS (ppt, pdf)